56
Treatment
9.4a. Parenteral Vasodilation Therapy in Patients
Hospitalized With HF
COR LOE
Recommendation
2b B-NR 1. In patients who are admitted with decompensated HF, in the
absence of systemic hypotension, intravenous nitroglycerin
or nitroprusside may be considered as an adjuvant to diuretic
therapy for relief of dyspnea.
9.4b. VTE Prophylaxis in Hospitalized Patients
COR LOE
Recommendation
1 B-R 1. In patients hospitalized with HF, prophylaxis for VTE is
recommended to prevent venous thromboembolic disease.
9.5. Evaluation and Management of Cardiogenic Shock
COR LOE
Recommendations
1 B-NR 1. In patients with cardiogenic shock, intravenous inotropic
support should be used to maintain systemic perfusion and
preserve end-organ performance.
2a B-NR 2. In patients with cardiogenic shock, temporary MCS is
reasonable when end-organ function cannot be maintained by
pharmacologic means to support cardiac function.
2a B-NR 3. In patients with cardiogenic shock, management by a
multidisciplinary team experienced in shock in reasonable.
2b B-NR 4. In patients presenting with cardiogenic shock, placement of
a PA line may be considered to define hemodynamic subsets
and appropriate management strategies.
2b C-LD 5. For patients who are not rapidly responding to initial shock
measures, triage to centers that can provide temporary MCS
may be considered to optimize management.
